Pharmacovigilance and Drug Safety Software Market Size, Share, Analysis Report

The Pharmacovigilance and Drug Safety Software Market is expected to be around US$ 280 Million by 2028 at a CAGR of 6.89% in the given forecast period.

Pharmacovigilance is also known as drug safety is defined as the science that mostly deals with the assessment, detections, monitoring, and prevention of damaging effects of pharmaceutical drugs. Pharmacovigilance and drug safety software mostly help in making, classifying, and reviewing of pharmacovigilance data and results in creating more knowledge and alertness among the healthcare professionals. It is classified based on the functionality of Adverse Event Reporting Software, Issue Tracking Software, Drug Safety Audits Software, and Fully Integrated Software. Pharmacovigilance is an integral and critical part of clinical research and these days it is increasing in many countries. Thus, growing the globalization in pharmacovigilance sector supports in drug safety software. It recovers the quality and efficacy of pharmacovigilance and drug safety software and is expected to favour the development of the market during the forecast period. Moreover, a rising health information functionality market will strengthen the usage of PV software over the forecast period, as it recovers patient health and decreases medical expenses.

The global Pharmacovigilance and Drug Safety Software market is segregated on the basis of Software Type as Fully Integrated Software, Adverse Event Reporting Software, Drug Safety Audits Software, and Issue Tracking Software. Based on Delivery Mode the global Pharmacovigilance and Drug Safety Software market is segmented in Cloud-based and On-premise. Based on End User the global Pharmacovigilance and Drug Safety Software market is segmented in Contract Research Organizations, Pharmaceutical and Biotech Companies, and Business Process Outsourcing.

The global Pharmacovigilance and Drug Safety Software market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Pharmacovigilance and Drug Safety Software market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Veeva Systems, IQVIA Inc, Ennov , AB Cube, United Biosource LLC, ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, EXTEDO, and others are among the major players in the global Pharmacovigilance and Drug Safety Software market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Pharmacovigilance and Drug Safety Software Market has been segmented as below:

Pharmacovigilance and Drug Safety Software Market, By Software Type

• Fully Integrated Software
• Adverse Event Reporting Software
• Drug Safety Audits Software
• Issue Tracking Software

Pharmacovigilance and Drug Safety Software Market, By Delivery Mode

• Cloud-based
• On-premise

Pharmacovigilance and Drug Safety Software Market, By End User

• Contract Research Organizations
• Pharmaceutical and Biotech Companies
• Business Process Outsourcing

Pharmacovigilance and Drug Safety Software Market, By Region

• North America
• Europe
• Asia-Pacific
• Rest of the World

Pharmacovigilance and Drug Safety Software Market, By Company

• Veeva Systems
• IQVIA Inc
• Ennov
• AB Cube
• United Biosource LLC
• ArisGlobal LLC
• Sparta Systems
• Oracle Corporation
• Sarjen Systems Pvt. Ltd
• EXTEDO

The report covers:

• Global Pharmacovigilance and Drug Safety Software market sizes from 2021 to 2028, along with CAGR for 2023-2028
• Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
• Global Pharmacovigilance and Drug Safety Software market trends, covering comprehensive range of consumer trends & manufacturer trends
• Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Pharmacovigilance and Drug Safety Software market
• Major market opportunities and challenges in forecast timeframe to be focused
• Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
• Comprehensive company profiles of the key industry players

Report Scope:

The global Pharmacovigilance and Drug Safety Software market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Pharmacovigilance and Drug Safety Software market share. Major industry players with significant revenue share include Veeva Systems, IQVIA Inc, Ennov , AB Cube, United Biosource LLC, ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, EXTEDO, and others.

Reasons to Buy this Report:

• Gain detailed insights on the Pharmacovigilance and Drug Safety Software industry trends
• Find complete analysis on the market status
• Identify the Pharmacovigilance and Drug Safety Software market opportunities and growth segments
• Analyse competitive dynamics by evaluating business segments & product portfolios
• Facilitate strategy planning and industry dynamics to enhance decision making

Customization

Customized report as per the requirement can be offered with appropriate recommendations.

Below are our New Reports :-

Bovine Vaccines market

brain tumour therapeutics market

Cholesterol Screening/ Cholesterol Lab Testing Services Market

Cemented Carbide Market

Bone and Joint Health Ingredients Market